The use of Pep: Trans vectors for the delivery of drugs into the central nervous system

International Congress Series

Volumn 1277, Issue , 2005, Pages 199-211

  Scherrmann, Jean Michel ^a   Temsamani, Jamal ^b  

^a INSERM   (France)

^b Synt:em   (France)

Author keywords

Analgesia; Blood brain barrier; Brain delivery; Cell penetrating peptide; Endocytosis; Peptide vector

Indexed keywords

EID: 33646452047     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.02.023     Document Type: Article

References (50)

1. Bickel U., et al. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2618-2622
2. Pardridge W.M. Transport of human recombinant brain-derived neurotrophic factor (BDNF) throught the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11 (1994) 738-740 (NY)
3. Food M.R., Sekyere E.O., and Richardson D.R. The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspeficic internalization and degradation of the protein. Eur. J. Biochem. 269 18 (2002) 4435-4445
4. Zhou X., and Huang L. Targeted delivery of DANN by liposomes and polymers. J. Control Release 19 (1992) 269-274
5. Borchardt G., et al. Uptake of surfactant-coated poly(methylmethacrylate)-nanoparticles by bovine brain microvessels endothelial cell monolayers. Int. J. Pharmacol. 110 (1994) 29-35
6. Kreuter J., et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674 (1995) 171-174
7. Rousselle C., et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57 (2000) 679-686
8. Rousselle C., et al. Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. J. Drug Target 10 (2002) 309-315
9. Rousselle C., et al. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. JPET 306 (2003) 1-6
10. Rousselle C., et al. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J. Pharmacol. Exp. Ther. 296 (2001) 124-131
11. Joliot A., et al. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1864-1868
12. Le Roux I., et al. Neurotrophic activity of the Antennapedia homeodomain depends on its specific DNA-binding properties. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9120-9124
13. Derossi D., et al. The third helix of the Antennapedia homeodomain translocates through biological membrane. J. Biol. Chem. 269 (1994) 10444-10450
14. Derossi D., et al. Cell internalization of the third-helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271 (1996) 18188-18193
15. Brudigou J., et al. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. Biochem. Biophys. Res. Commun. 214 (1995) 685-693
16. Drin G., et al. Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry 40 (2001) 1824-1834
17. Frankel A.D., and Pabo C.O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
18. Fawell S., et al. Tat mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 664-668
19. Vivès E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16077
20. Suzuki T., et al. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 (2001) 2437-2443
21. Kokryakov V.N., et al. Protegrins: leukocyte antimicrobial peptides that combine feature of corticostatic defensins and tachyplesins. FEBS. Lett. 327 (1993) 231-236
22. Mangoni M.E., et al. Change in membrane permeability induced by protegrin 1. Implication of disulphide bridges for pore formation. FEBS. Lett. 383 (1996) 93-98
23. Pooga M., et al. Cell penetration by transportan. FASEB. J. 12 (1998) 67-77
24. Hällbrink M., et al. Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta. 1515 (2001) 101-109
25. Scheller A., et al. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J. Pept. Sci. 5 (1999) 185-194
26. Dathe M., et al. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35 (1996) 12612-12622
27. Chaloin L., et al. Conformations of primary amphipathic carrier peptides in membrane mimicking environments. Biochemistry 36 (1997) 11179-11187
28. Vidal P., et al. Interactions of primary amphipathic vector peptides with membranes: conformational consequences and influence on cellular localization. J. Membr. Biol. 162 (1998) 259-264
29. Mitchell D.J., et al. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56 (2000) 318-325
30. Mazel M., et al. Doxorubicin-peptide conjugates overcome multidrug resistance. Anticancer Drugs 12 (2001) 107-116
31. Blanc E., Bonnafous C., Merida P. et al. Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel. Anticancer Drugs. 15 in press.
32. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
33. Tsuji A. P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier. Ther. Drug Monit. 20 (1998) 588-590
34. Kalenikova E.I., et al. Farmakokinetica dalargina. Vopr. Med. Khim. 34 (1988) 75-83
35. Letvin N.L., et al. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates, In vivo stability of disulfide-linked immunotoxin conjugates. J. Clin. Invest. 77 (1986) 977-984
36. Schroeder U., Sommerfield P., and Sabel B.A. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides 19 (1998) 474-479
37. Abbott F.V., and Palmour R.M. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 43 (1988) 1685-1695
38. Paul D., et al. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251 (1989) 477-483
39. Frances B., et al. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 262 (1992) 25-31
40. Bickel U., et al. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat. J. Pharmacol. Exp. Ther. 278 (1996) 107-113
41. Wu D., et al. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab. Dispos. 25 (1997) 768-771
42. Schwarze S.R., et al. In vivo protein transduction of a biologically active protein in the mouse. Science 285 (1999) 1569-1572
43. Cao G., et al. In vivo delivery of a Bcl-xL fusion protein containing the Tat protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22 (2002) 5423-5431
44. Kilic E., et al. Intravenous TAT-Bcl-xL is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52 (2002) 617-622
45. Asoh S., et al. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 17107-17112
46. Hardebo J.E., and Kahrstrom J. Endothelial negative surface charge areas, and blood-brain barrier function. Acta. Physiol. Scand. 125 (1985) 495-499
47. Vordbrodt A.W. Ultrastructural cytochemistry of blood-brain barrier endothelia. Prog. Histochem. Cytochem. 18 (1988) 1-99
48. Bar R.S., et al. Insulin binding to microvascular endothelium of intact heart: a kinetic and morphometric analysis. Am. J. Physiol. 244 (1983) 477-482
49. Virgintino D., et al. An immunohistochemical and morphometric study on astrocytes and microvasculature in the human cerebral cortex. Histochem. J. 29 (1997) 655-660
50. Bertossi M., et al. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct. Pathol. 21 (1997) 41-49